Ocular Therapeutix (OCUL) FCF Margin Growth (1y) (2015 - 2026)
Ocular Therapeutix (OCUL) FCF Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ocular Therapeutix | 1.93 Bn | 1.93 Bn | 9.46 Mn | -18,857.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18,857.00 |
| Dec 31, 2025 | -19,977.00 |
| Sep 30, 2025 | -15,275.00 |
| Jun 30, 2025 | -27,010.00 |
| Mar 31, 2025 | -20,454.00 |
| Dec 31, 2024 | -4,006.00 |
| Sep 30, 2024 | -21,979.00 |
| Jun 30, 2024 | -427.00 |
| Mar 31, 2024 | -5,649.00 |
| Dec 31, 2023 | -6,410.00 |
| Sep 30, 2023 | 9,456.00 |
| Jun 30, 2023 | -5,564.00 |
| Mar 31, 2023 | -3,263.00 |
| Dec 31, 2022 | -396.00 |
| Sep 30, 2022 | -590.00 |
| Jun 30, 2022 | 8,386.00 |
| Mar 31, 2022 | 9,459.00 |
| Dec 31, 2021 | -4,474.00 |
| Sep 30, 2021 | 13,527.00 |
| Jun 30, 2021 | 77,218.00 |